Cardiac Autonomic Changes After Endoscopic Thoracic Sympathectomy For Essential Palmar Hyperhidrosis
Launched by UNIVERSITY OF CAMPANIA LUIGI VANVITELLI · Apr 5, 2016
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
It was an unicenter prospective study performed at Thoracic Surgery Unit of Second University of Naples. Patients with severe EPH were randomly assigned to Sympathectomy or Sympathicotomy Group in 1:1 ratio .
Bilateral ETSs were performed in a one-stage procedure by the same surgeon. General anaesthesia using single-lung ventilation technique was performed and patient was placed in standard lateral thoracotomy position. Immediately after the induction of anaesthesia, a local infiltration with 2% lidocaine and epinephrine was injected at each port 5 minutes before the incision to reduce pos...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age more than 18 years
- • Severe hyperhidrosis
- Exclusion Criteria:
- • Contraindications for general anaesthetic procedure and/or for selective endotracheal intubation
- • Previous pleural or lung diseases that make difficult the access to pleural cavityù
- • Cardiac diseases and/or taking medications with cardiac effects
- • Secondary hyperhidrosis including hyperthyroidism, acute and chronic infections, malignancy, and immunologic disorder
- • Mild or moderate palmar hyperhidrosis
About University Of Campania Luigi Vanvitelli
The University of Campania Luigi Vanvitelli is a distinguished academic institution located in Italy, renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive expertise in biomedical sciences to conduct innovative studies that address critical health challenges. With a focus on ethical standards and patient safety, the university collaborates with various healthcare professionals and research entities to facilitate groundbreaking clinical investigations, ultimately contributing to the development of new therapies and enhancing medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Mario Santini, MD
Study Chair
University of Campania Luigi Vanvitelli
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials